Skip to main content
SpringerLink
Log in

Nuklearmedizinische Diagnostik und Therapie von Lebermetastasen

  • Chapter
LeberMetastasen

  • 57 Accesses

Zusammenfassung

Ndiesem Buchkapitel soll die Problematik von Lebermetastasen, die eine Schnittmenge der verschiedensten Tumorerkrankungen bilden, aus nuklearmedizinischer Sicht beleuchtet werden. Mindestens so wichtig wie die Diagnostik sind dabei die vielfältigen therapeutischen Ansätze, die die Nuklearmedizin in die moderne Onkologie einbringt, und die noch weitreichende Umwälzungen dieses Fachgebiets gerade zu Beginn des neuen Jahrtausends mit sich bringen

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Atmaram SH, Ganatra RD, Sharma SM, Ramanna L (1975) Functioning metastases in liver from thyroid carcinoma: Case report. J Nucl Med 16: 919–921

    PubMed  CAS  Google Scholar 

  • Avril N, Scheidhauer K, Kuhn W (2000) Breast cancer. In: Wieler HJ, Coleman RE (eds) PET in clinical oncology. Springer Steinkopff, Darmstadt, pp 355–372

    Google Scholar 

  • Bell E, Grünwald F (1999) Radiojodtherapie bei benignen und malignen Schilddrüsenerkrankungen. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Bender H, Bangard N, Metten N, Bangard M, Mezger J, Schomburg A, Biersack HJ (1999) Possible role of FDG-PET in the early prediction of therapy outcome in liver metastases of colorectal cancer.Hybridoma 18: 87–91

    Article  PubMed  CAS  Google Scholar 

  • Bender H, Straehler-Pohl HJ (2000) PET in head and neck tumors. In: Wieler HJ, Coleman RE (eds) PET in clinical oncology. Springer Steinkopff, Darmstadt, pp 155–167

    Google Scholar 

  • Bonnette P, Epardeau B, Frachon I, Bisson A, Caubarrere I, Mignot L, Corone C (1999) Report of 2 cases of pleural recurrences of surgically treated bronchogenic carcinoids. Diagnostic and therapeutic problems. Rev Mal Respir 16: 85–88

    CAS  Google Scholar 

  • Boykin KN, Zibari GB, Lilien DL, McMillan RW, Aultman DF, McDonald JC (1999) The use of FDGpositron emission tomography for the evaluation of colorectal metastases of the liver. Am Surg 65: 1183–1185

    PubMed  CAS  Google Scholar 

  • Bretagne JF, Raoul JL, Bourguet P et al. (1988) Hepatic artery injection of I-131-labeled Lipiodol. Part 2: Preliminary results of therapeutic use in patients with hepatocellular carcinoma and liver metastases. Radiology 168: 547–550

    PubMed  CAS  Google Scholar 

  • Britton KE, Granowska M(1998) The diagnostic role of radiolabeled antibodies. In: Murray IPC, Ell PJ (eds) Nuclear medicine in clinical diagnosis and treatment, 2nd edn. Churchill Livingstone, Edinburgh London New York, pp 871–892

    Google Scholar 

  • Casara D, Busnardo B, Cimitan M (1981) Liver metastases from differentiated thyroid carcinoma. J Nucl Med Allied Sei 25: 53–54

    CAS  Google Scholar 

  • Castellani MR, Di Bartolomeo M, Maffioli L, Zilembo N, Gasparini M, Buraggi GL (1991) [1311] metaiodobenzylguanidine therapy in carcinoid tumors. J Nucl Biol Med 35: 349–351

    PubMed  CAS  Google Scholar 

  • Cavalieri RR (1996) Nuclear imaging in the management of thyroid carcinoma. Thyroid 6: 485–492

    Article  PubMed  CAS  Google Scholar 

  • Chatal JF, Mah M(1998) Therapeutic use of radiolabeled antibodies. In: Murray IPC, Ell PJ(eds) Nuclear medicine in clinical diagnosis and treatment, 2nd edn. Churchill Livingstone, Edinburgh London New York, pp 1101–1114

    Google Scholar 

  • Clarke SEM(1998) Radioiodine therapy of the thyroid. In: Murray IPC, Ell PJ (eds) Nuclear medicine in clinical diagnosis and treatment, 2nd edn. Churchill Livingstone, Edinburgh London New York, pp 1049–1062

    Google Scholar 

  • Crippa F, Gavazzi C, Bozzetti F et al. (1997) The influence of blood glucose levels on [18F] fluorodeoxyglucose (FDG) uptake in cancer: A PET study in liver metastases from colorectal carcinomas. Tumori 83: 748–752

    PubMed  CAS  Google Scholar 

  • Delbeke D, Vitola JV, Sandler MP et al. (1997)Staging recurrent metastatic colorectal carcinoma with PET.J Nucl Med 38: 1196–1201

    CAS  Google Scholar 

  • Dimitrakopoulou A, Strauss LG, Clorius JH et al. (1993) Studies with positron emission tomography after systemic administration of fluorine-18-uracil in patients with liver metastases from colorectal carcinoma. J Nucl Med 34: 1075–1081

    PubMed  CAS  Google Scholar 

  • Dimitrakopoulou-Strauss A, Strauss LG, Schlag P et al. (1998 a) Intravenous and intra-arterial oxygen-15-labeled water and fluorine-18-labeled fluorouracil in patients with liver metastases from colorectal carcinoma. J Nucl Med 39: 465–473

    PubMed  CAS  Google Scholar 

  • Dimitrakopoulou-Strauss A, Strauss LG, Schlag P, Hohenberger P, Möhler M, Oberdorfer F, van Kaick G(1998b) Fluorine-18-fluorouracil to predict therapy response in liver metastases from colorectal carcinoma. J Nucl Med 39: 1197–1202

    PubMed  CAS  Google Scholar 

  • Dresel S, Tatsch K, Zachoval R, Hahn K (1996) llllN-Octreotide- und 1231-MIBG-Szintigraphie in der Diagnostik von Dünndarmkarzinoiden. Nuklearmedizin 35: 53–58

    PubMed  CAS  Google Scholar 

  • Eising EG, Farahati J, Bier D, Knust EJ, Reiners C (1995) Somatostatinrezeptor-Szintigraphie bei medullären Schilddrüsenkarzinomen, GEP-Tumoren und Karzinoiden. Nuklearmedizin 34: 1–7

    CAS  Google Scholar 

  • Findlay M, Young H, Cunningham D et al. (1996) Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: Correlation with tumor response to fluorouracil. J Clin Oncol 14: 700–708

    PubMed  CAS  Google Scholar 

  • Fischer M (1998) Alternative approaches to targeting therapy. In: Murray IPC, Ell PJ (eds) Nuclear medicine in clinical diagnosis and treatment, 2nd edn. Churchill Livingstone, Edinburgh London New York, pp 1115–1121

    Google Scholar 

  • Frank-Raue K, Bihl H, Dorr U, Buhr H, Ziegler R, Raue F (1995) Somatostatin receptor imaging in persistent medullary thyroid carcinoma. Clin Endocrinol 42: 31–37

    Article  CAS  Google Scholar 

  • Fröhlich A, Diederichs CG, Staib L, Vogel J, Beger HG, Reske SN (1999)Detection of liver metastases from pancreatic cancer using FDG PET.J Nucl Med 40: 250–255

    Google Scholar 

  • Furusawa M, Shimomura O, Tomiguchi S et al. (1992) Radionuclide therapy of Sipple Syndrome using iodine-131 metaiodobenzylguanidine. Kaku Igaku 29: 1133–1138

    PubMed  CAS  Google Scholar 

  • Graves MW, Zukerberg B, Walace K, Duncan D, Scheff A (1996) Isolated liver metastases from follicular thyroid cancer. Clin Nucl Med 21: 147–148

    Article  PubMed  CAS  Google Scholar 

  • Grünwald F, Ruhlmann J, Kozak B, Overlack A, Christ F, Hotze A, Biersack HJ (1988) Nuklearmedizinische Diagnostik und Therapie von Fernmetastasen eines Phäochromozytoms. Dtsch Med Wochenschr 113: 297–299

    Article  PubMed  Google Scholar 

  • Grünwald F, Menzel C, Bender H et al. (1998) Redifferentiation therapy - induced radioiodine uptake in thyroid cancer. J Nucl Med 39: 1903–1906

    PubMed  Google Scholar 

  • Grünwald F, Kälicke T, Feine U et al. (1999) Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: Results of a multicentre study. Eur J Nucl Med 26: 1547–1552

    Article  PubMed  Google Scholar 

  • Guglielmi R, Pacella CM, Dottorini ME et al. (1999) Severe thyrotoxicosis due to hyperfunctioning liver metastasis from follicular carcinoma: Treatment with (131)1 and interstitial laser ablation. Thyroid 9: 173–177

    Article  PubMed  CAS  Google Scholar 

  • Herba MJ, Illescas FF, Thirlwell MP, Boos GJ, Rosenthall L, Atri M, Bret PM (1988) Hepatic malignancies: Improved treatment with intraarterial Y-90. Radiology 169: 311–314

    PubMed  CAS  Google Scholar 

  • Hoefnagel CA, Lewington VJ (1998) MIBG therapy. In: Murray IPC, Ell PJ (eds) Nuclear medicine in clinical diagnosis and treatment, 2nd edn. Churchill Livingstone, Edinburgh London New York, pp 1067–1081

    Google Scholar 

  • Hoefnagel CA, Taal BG, Valdes Olmos RA (1991) Role of [131I] metaiodobenzylguanidine therapy in carcinoids. J Nucl Biol Med 35: 346–348

    Google Scholar 

  • Hohenberger P, Strauss LG, Lehner B, Frohmuller S, Dimitrakopoulou A, Schlag P (1993) Perfusion of colorectal liver metastases and uptake of fluorouracil assessed by H2(15)0 and [18F] uracil positron emission tomography (PET). Eur J Cancer 29A: 1682–1686

    Article  PubMed  CAS  Google Scholar 

  • Hosten N, Kreissig R, Puls R et al. (2000) Fusion von CT- und PET-Daten: Methode und klinische Bedeutung am Beispiel der Planung der laserinduzierten Thermotherapie von Lebermetastasen. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 172: 630–635

    Article  PubMed  CAS  Google Scholar 

  • Kälicke T, Schmitz A, Risse JH et al. (2000) Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: Results of histologically confirmed cases. Eur J Nucl Med 27: 524–528

    Article  PubMed  Google Scholar 

  • Kim CK, Worsley DF, Lentle BC (1998) Scintigraphic diagnosis of tumors of the liver. In: Murray IPC, Ell PJ (eds) Nuclear medicine in clinical diagnosis and treatment, 2nd edn. Churchill Livingstone, Edinburgh London New York, pp 775–782

    Google Scholar 

  • Kissel J, Brix G, Bellemann ME et al. (1997) Pharmacokinetic analysis of 5-[18F] fluorouracil tissue concentrations measured with positron emission tomography in patients with liver metastases from colorectal adenocarcinoma. Cancer Res 57: 3415–3423

    PubMed  CAS  Google Scholar 

  • Kiemenz B, Taaleb KM(2000) Lung cancer. In: Wieler HJ, Coleman RE (eds) PET in clinical oncology. Springer Steinkopff, Darmstadt, pp 193–210

    Google Scholar 

  • Knapp WH, Moser E, Bares R, Reske SN (1999) Tumoren. In: Büll U, Schicha H, Biersack HJ ETAL Etal. (Hrsg) Nuklearmedizin, 3. Aufl Thieme, Stuttgart New York, S 454–505

    Google Scholar 

  • Konsensus Onko-PET (1997) Ergebnisse der 2. interdisziplinären Konsensuskonferenz in Ulm, 12. 9. 1997. Nuklearmedizin 36: 45–46

    Google Scholar 

  • Krebs B, Frey M, Lellig U (1989) Jodspeichernde, hormonproduzierende Lebermetastase eines follikulären Schilddrüsenkarzinoms. RoFo Fortschr Geb Rontgenstr Nuklearmed 50: 489

    Article  Google Scholar 

  • Krenning EP, Kwekkeboom DJ, Reubi JC (1998) Peptide receptor scintigraphy in oncology. In: Murray IPC, Ell PJ (eds) Nuclear medicine in clinical diagnosis and treatment, 2nd edn. Churchill Livingstone, Edinburgh London New York, pp 859–870

    Google Scholar 

  • Krenning EP, Valkema R, Kooij PP et al. (2000) The role of radioactive somatostatin and its analogues in the control of tumor growth. Recent Results Cancer Res 153: 1–13

    Article  PubMed  CAS  Google Scholar 

  • Lai DT, Fulham M, Stephen MS et al. (1996) The role of whole-body positron emission tomography with [ 18F)fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver. Arch Surg 131: 703–707

    PubMed  CAS  Google Scholar 

  • Lastoria S, Maurea S, Caraco C et al. (1993) Iodine-131 metaiodobenzylguanidine scintigraphy for localization of lesions in children with neuroblastoma: Comparison with computed tomography and ultrasonography. Eur J Nucl Med 20: 1161–1167

    Article  PubMed  CAS  Google Scholar 

  • Liewendahl K, Välimäki M, Taavitsainen M(1993) Localization of hepatic metastases by radiolabelled anti-carcinoembryonic antigen antibody and meta-iodobenzylguanidine in a patient with medullary thyroid carcinoma. Eur J Nucl Med 20: 551–554

    Article  PubMed  CAS  Google Scholar 

  • Mantaka P, Strauss AD, Strauss LG et al. (1999) Detection of treated liver metastases using fluorine-18-fluordeoxyglucose (FDG) and positron emission tomography (PET). Anticancer Res 19: 4443–4450

    PubMed  CAS  Google Scholar 

  • Moehler M, Dimitrakopoulou-Strauss A, Gutzier F, Raeth U, Strauss LG, Stremmel W (1998) 18F-labeled fluorouracil positron emission tomography and the prognoses of colorectal carcinoma patients with metastases to the liver treated with 5-fluorouracil. Cancer 83: 245–253

    Article  PubMed  CAS  Google Scholar 

  • Moretti JL, Archer CM, Urbain JL (1998) Molecular biology in nuclear oncology. In: Murray IPC, Ell PJ (eds) Nuclear medicine in clinical diagnosis and treatment, 2nd edn. Churchill Livingstone, Edinburgh London New York, pp 893–910

    Google Scholar 

  • Nakagami Y, Nomura K, Kusakabe K, Miko N, Tsushima T, Demura H (1990) A case of malignant pheochromocytoma treated with 1311-metaiodobenzylguanidine and alpha-methyl-p-tyrosine. Jpn J Med 29: 329–333

    Article  PubMed  CAS  Google Scholar 

  • Nakamoto Y, Higashi T, Sakahara H, Tamaki N, Kogire M, Imamura M, Konishi J (1999) Contribution of PET in the detection of liver metastases from pancreatic tumours. Clin Radiol 54: 248–252

    Article  PubMed  CAS  Google Scholar 

  • Ogunbiyi OA, Flanagan FL, Dehdashti F et al. (1997) Detection of recurrent and metastatic colorectal cancer: Comparison of positron emission tomography and computed tomography. Ann Surg Oncol 4: 613–620

    Article  PubMed  CAS  Google Scholar 

  • Orsolon P, Bagni B (1995) 1311 MIBG/lllIn octreotide mismatch in a patient with liver metastases secondary to a carcinoid of unknown origin. Minerva Endocrinol 20: 145–147

    PubMed  CAS  Google Scholar 

  • Otte A, Herrmann R, Heppeler A et al. (1999) Yttrium-90 DOTATOC: first clinical results. Eur J Nucl Med 26: 1439–1447

    Article  PubMed  CAS  Google Scholar 

  • Perring S, Hind R, Fleming J et al. (1994) Dosimetrie assessment of radiolabelled Lipiodol as a potential therapeutic agent in colorectal liver metastases using combined CT and SPECT. Nucl Med Commun 15: 34–38

    Article  PubMed  CAS  Google Scholar 

  • Prvulovich EM, Stein RC, Bomanji JB, Ledermann JA, Taylor I, Ell PJ (1998) Iodine-131-MIBG therapy of a patient with carcinoid liver metastases. J Nucl Med 39: 1743–1745

    PubMed  CAS  Google Scholar 

  • Raoul JL, Bourguet P, Bretagne JF et al. (1988) Hepatic artery injection of I-131-labeled Lipiodol. Part 1: Biodistribution study results in patients with hepatocellular carcinoma and liver metastases. Radiology 168: 541–545

    PubMed  CAS  Google Scholar 

  • Raoul JL, Guyader D, Bretagne JF et al. (1994) Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: Intra-arterial iodine-131-iodized oil versus medical support. J Nucl Med 35: 1782–1787

    PubMed  CAS  Google Scholar 

  • Reske SN, Bares R, Büll U, Guhlmann A, Moser E, Wannenmacher MF(1996) Clinical value of positron emission tomography (PET) in oncologic questions: Results of an interdiseiplinary consensus conference. Nuklearmedizin 35: 42–52

    PubMed  CAS  Google Scholar 

  • Risse JH, Grünwald F, Bender H, Schüller H, Van Roost D, Biersack HJ (1999a) Recombinant human TSH in thyroid cancer and hypopituitarism due to sella metastasis. Thyroid 9: 1253–1256

    Article  PubMed  CAS  Google Scholar 

  • Risse JH, Grünwald F, Strunk H, Kleinschmidt R, Bender H, Biersack HJ (1999b) I-131-Lipiodol therapy in liver neoplasms. Hybridoma 18: 83–85

    Article  PubMed  CAS  Google Scholar 

  • Risse JH, Grünwald F, Kersjes W, Ayanna S, Palmedo H, Bender H, Biersack HJ (1999c) Intraarterielle Therapie von Lebermetastasen bei Mamma-Carcinom mit J-131-Lipiodol. Nuklearmedizin 38: A98

    Google Scholar 

  • Risse JH, Palmedo H, Bender H (2000a) Malignant Melanoma. In: Bender H, Palmedo H, Biersack HJ, Valk PE (eds) Atlas of clinical PET in oncology. Springer, Berlin Heidelberg New York Tokyo, pp 37–49

    Google Scholar 

  • Risse JH, Grünwald F, Kersjes W et al. (2000b) Intraarterial HCC therapy with I-131-Lipiodol. Cancer Biother Radio 15: 65–70

    Article  CAS  Google Scholar 

  • Rotman-Pikielny P, Reynolds JC, Barker WC, Yen PM, Skarulis MC, Sarlis NJ (2000) Recombinant human thyrotropin for the diagnosis and treatment of a highly functional metastatic Struma ovarii. J Clin Endocrinol Metab 85: 237–244

    Article  PubMed  CAS  Google Scholar 

  • Rutgers EJT, Muller SH, Hoefnagel CA (1998) Use of intraoperative probes in surgical oncology. In: Murray IPC, Ell PJ (eds) Nuclear medicine in clinical diagnosis and treatment, 2nd edn. Churchill Livingstone, Edinburgh London New York, pp 1025–1036

    Google Scholar 

  • Schicha H, Dietlein M, Scheidhauer K (1999) Therapie mit offenen radioaktiven Stoffen. In: Büll U, Schicha H, Biersack HJ ETAL Etal. (Hrsg) Nuklearmedizin, 3. Aufl. Thieme, Stuttgart New York, S 512–545

    Google Scholar 

  • Schlumberger MJ (1998) Papillary and follicular thyroid carcinoma. N Engl J Med 338: 297–306

    Article  PubMed  CAS  Google Scholar 

  • Schlumberger MJ (Hrsg) (1999) RhTSH: New directions in detection and management of well-differentiated thyroid carcinoma. J Endocrinol Invest 22 (Suppl): 1–41

    Google Scholar 

  • Schmitz A, Risse JH, Kälicke T, Grünwald F, Biersack HJ, Schmitt O (2000) FDG-PET zur Diagnostik und Verlaufskontrolle entzündlicher Prozesse: Erste Ergebnisse aus orthopädischer Sicht. Z Orthop 138: 407–412

    Article  PubMed  CAS  Google Scholar 

  • Scott AM, Macapinlac H, Zhang J et al. (1995) Image registration of SPECT and CT images using an external fiduciary band and three-dimensional surface fitting in metastatic thyroid cancer. J Nucl Med 36: 100–103

    PubMed  CAS  Google Scholar 

  • Shah DH, Samuel AM (1996) Metastasis to the liver in well-differentiated carcinoma of the thyroid. Thyroid 6: 607–611

    Article  PubMed  CAS  Google Scholar 

  • Shalaby-Rana E, Majd M, Andrich MP, Movassaghi N (1997) In-111 pentetreotide scintigraphy in patients with neuroblastoma. Comparison with 1–131 MIBG, N-Myc oncogene amplification, and patient outcome. Clin Nucl Med 22: 315–319

    Article  PubMed  CAS  Google Scholar 

  • Siproudhis L, Lescouarch J, Bretagne JF et al. (1991) Contribution of 1311 MIBG scintigraphy in the diagnosis of carcinoid tumors of the digestive tract. Experience of 14 cases. Gastroenterol Clin Biol 15: 789–793

    CAS  Google Scholar 

  • Smith MC, Liu J, Chen T et al. (2000) OctreoTher: Ongoing early clinical development of a somatostatin-receptor-targeted radionuclide antineoplastic therapy. Digestion 62 Suppl 1: 69–72

    Article  PubMed  CAS  Google Scholar 

  • Sone T, Fukunaga M, Otsuka N et al. (1985) Metastatic medullary thyroid cancer: Localization with iodine-131 metaiodobenzylguanidine. J Nucl Med 26: 604–608

    PubMed  CAS  Google Scholar 

  • Troncone L, Rufini V(1998) Radiolabeled metaiodobenzylguanidine in the diagnosis of neural crest tumors. In: Murray IPC, Ell PJ (eds) Nuclear medicine in clinical diagnosis and treatment, 2nd edn. Churchill Livingstone, Edinburgh London New York, pp 843–857

    Google Scholar 

  • Vitola JV, Delbeke D, Sandler MP et al. (1996a) Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg 171: 21–26

    Article  PubMed  CAS  Google Scholar 

  • Vitola JV, Delbeke D, Meranze SG, Mazer MJ, Pinson CW (1996b) Positron emission tomography with F-18-fluorodeoxyglucose to evaluate the results of hepatic chemoembolization. Cancer 78: 2216–2222

    Article  PubMed  CAS  Google Scholar 

  • Vogl TJ, Trapp M, Schroeder H et al. (2000) Transarterial chemoembolization for hepatocellular carcinoma: Volumetrie and morphologic CT criteria for assessment of prognosis and therapeutic success results from a liver transplantation center. Radiology 214: 349–357

    PubMed  CAS  Google Scholar 

  • Wahl RL (1998) Positron emission tomography: Applications in oncology. In: Murray IPC, Ell PJ (Hrsg) Nuclear medicine in clinical diagnosis and treatment, 2nd edn. Churchill Livingstone, Edinburgh London New York, pp 911–940

    Google Scholar 

  • Woolfenden JM, Waxman AD, Wolfstein RS, Siemsen JK (1975) Scintigraphic elvaluation of liver metastases from thyroid carcinoma. J Nucl Med 16: 669–671

    PubMed  CAS  Google Scholar 

  • Yasuda S, Makuuchi Y, Sadahiro S, Mukai M, Tokunaga N, Tajima T, Shohtsu A (1998) Colorectal cancer recurrence in the liver: Detection by PET. Tokai J Exp Clin Med 23: 167–171

    PubMed  CAS  Google Scholar 

  • Yonekura Y, Benua RS, Brill AB et al. (1982) Increased accumulation of 2-deoxy-2-[18F]Fluoro-D-glucose in liver metastases from colon carcinoma. J Nucl Med 23: 1133–1137

    PubMed  CAS  Google Scholar 

  • Zuetenhorst H, Taal BG, Boot H, Valdes Olmos R, Hoefnagel C (1999) Long-term palliation in metastatic carcinoid tumours with various applications of meta-iodobenzylguanidin (MIBG): Pharmacological MIBG, 1311-labelled MIBG andthe combination. Eur J Gastroenterol Hepatol 11: 1157–1164

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. J. H. Risse
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Grünwald
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Zentrum der Radiologie, Institut für Diagnostische und Interventionelle Radiologie, Klinikum der J.-W.-Goethe-Universität Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany

    Thomas J. Vogl , Martin G. Mack  & Jörn O. Balzer ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Risse, J.H., Grünwald, F. (2002). Nuklearmedizinische Diagnostik und Therapie von Lebermetastasen. In: Vogl, T.J., Mack, M.G., Balzer, J.O. (eds) LeberMetastasen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59385-7_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59385-7_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-63958-6

  • Online ISBN: 978-3-642-59385-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation